David Lock is the Executive Director of New Product Planning for Diabetes and Obesity at Eli Lilly and Company, where they advance treatments for metabolic diseases and develop strategic initiatives. With a career beginning in 2000, David has demonstrated expertise in product development, marketing, and commercialization across various roles at Eli Lilly, including Director of Operations and Senior Director of Diabetes New Product Planning. They have led cross-functional teams and managed significant product lines globally, while also utilizing Six Sigma methodologies to drive improvements. David holds a degree in Biology and Computer Science from McMaster University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices